# Deborah Dunsire
Principales episodios de podcast
Actualizado:
deborah dunsire (b. 1963) is a medical doctor and pharmaceutical executive who has served as CEO of multiple research companies.
== Career ==
At a 2013 career event at Bentley University, Dunsire remarked that she "...never intended to go into business.
Lundbeck's CEO on Developing Breakthrough Medications & Allocating Funding
How do CEOs determine focus areas and allocate budget to R&D initiatives? In this episode, Deborah Dunsire, four-time chief executive of public and private companies shares her experience. Dunsire has been the CEO of Lundbeck since 2018 — overseeing teams that discover new medicines in Copenhagen a…
Biotech From A To Z With Lundbeck
Recorded on 08/09/22
Cowen analyst Yaron Werber speaks to Deborah Dunsire, President & CEO of Lundbeck, about the similarities and differences between leading smaller, US-based biotechs and larger pharmaceutical companies with a global footprint. We discuss the importance of having a long-term out…
3: Lundbeck ready to make acquisitions
Danish pharmaceutical company Lundbeck [CPH: LUN] is poised for a run of M&A to replenish its drug pipeline. We caught up with our Nordics reporter, Karoliina Liimatainen, who spoke recently with the company's chief executive, Deborah Dunsire, and has more on the company's plans for growth.
65. Leadership lessons from Deborah Dunsire, CEO At Lundbeck Pharmaceuticals.
Deborah Dunsire is an experienced CEO with a demonstrated history of building highly successful teams within the biotech and pharmaceuticals industry. At Lundbeck Pharmaceuticals, employees can be their whole selves and discuss their physical and mental health issues with their managers. Deborah is…
68. Deborah Dunsire's view on circularity and why the change needs to come from leaders.
Lundbeck, the Danish pharmaceutical company, is considered to be one of the most sustainable global companies. Their CEO Deborah Dunsire explains in this episode of 16 Minutes of CARE what efforts they make within the company and how they collaborate with suppliers to reduce their carbon footprint.…
Deborah Dunsire on trends in drug development, investments, regulation, and her advice on key skills for growing into a position of leadership
Interviewed by Sisterhood editorial board member Erika Smith, Deborah Dunsire describes her career path, how medicine is making progress in areas such as neuroscience, the cyclical nature of biotech and what it means for investment risk, and more.
Henri Termeer, The Ultimate Caregiver
The latest episode of In Sickness. Men and the Culture of Caregiving honors Henri Termeer’s legacy as the ultimate patient advocate and caregiver. What better way to offer this tribute than with a group of people who knew him best and considered him a friend and mentor. Deborah Dunsire, John Crowle…
Deborah Dunsire on leading in today’s biopharma landscape
In this episode, we talk to Deborah Dunsire, board chair at Neurvati Neurosciences, multiple times board member, and a former CEO of Lundbeck. With more than 3 decades of experience, Deborah has navigated organizations of every size through change, uncertainty, and opportunity.We explore what it ta…
Building, Breaking, and Rebuilding Biotech | Deborah Dunsire
See the episode breakdown with time stamps below:
0:00 – Cold open: the "unexpected collaboration" teaser
0:35 – Growing up in Zimbabwe and an unplanned path into medicine
5:41 – The "9-month detour" into pharma that turned into a 30-year career
20:01 – Learning to lead: finance, business instincts…
MOTOR DE BÚSQUEDA DE PODCAST
Puede utilizar nuestro sitio web para buscar podcasts de3,822,208y episodios de195,460,787por personas, lugares o temas.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
EDITAR
Gracias por ayudar a mantener actualizada la base de datos de podcasts.
